Search Results

The product title you are looking for is no longer available. Other similar products that may interest you are listed below:

Refine your Search

Results for 'Biosimilars Series'
Title Publication Date Price Relevance
The Pharmaceutical Market: France Oct 2011 £595 100%
The Pharmaceutical Market: Estonia Oct 2011 £595 99%
The Pharmaceutical Market: Romania Oct 2011 £595 98%
The Pharmaceutical Market: Lithuania Oct 2011 £595 98%
The Pharmaceutical Market: Hungary Oct 2011 £595 98%
The Pharmaceutical Market: Poland Oct 2011 £595 98%
The Pharmaceutical Market: Latvia Oct 2011 £595 97%
Global Biosimilars
A return to optimism?
 Jan 2012 £1,295 97%
The Pharmaceutical Market: Greece Oct 2011 £595 97%
The Pharmaceutical Market: Slovakia Oct 2011 £595 97%
The Pharmaceutical Market: Malaysia Oct 2011 £595 97%
The Pharmaceutical Market: Slovenia Oct 2011 £595 97%
The Pharmaceutical Market: Czech Republic Oct 2011 £595 97%
The Pharmaceutical Market: Ukraine Oct 2011 £595 97%
The Pharmaceutical Market: Bulgaria Oct 2011 £595 97%
The Pharmaceutical Market: Italy Oct 2011 £595 97%
The Pharmaceutical Market: Croatia Oct 2011 £595 96%
The Pharmaceutical Market: Finland Oct 2011 £595 96%
The Pharmaceutical Market: Sweden Oct 2011 £595 96%
The Pharmaceutical Market: South Korea Oct 2011 £595 96%
The Pharmaceutical Market: Israel Oct 2011 £595 95%
The Pharmaceutical Market: South Africa Oct 2011 £595 95%
The Pharmaceutical Market: Germany Oct 2011 £595 95%
The World Generic Market Report
2011
 Feb 2011 £795 95%
Biosimilar/Follow-on Biologics Market Report & Forecast
A Focus on the US (2011-2020)
 Oct 2011 £760 95%
The Pharmaceutical Market: Ireland Oct 2011 £595 95%
The Pharmaceutical Market: Denmark Oct 2011 £595 95%
The Pharmaceutical Market: UK Oct 2011 £595 95%
The Pharmaceutical Market: Portugal Oct 2011 £595 95%
The Pharmaceutical Market: Turkey Oct 2011 £595 94%